Concepedia

Phase I evaluation of AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced malignancies

John D. Powderly, Alexander I. Spira, Rafael Selgas Gutiérrez, Daniel DiRenzo, Akshata R. Udyavar, Joyson Karakunnel, Aimee Rieger, Jill Colabella, Dominic W. Lai, P. de Souza

Annals of Oncology · 2019 · 20 citations · 0 references

DOIFull text

Open access

Concepts